Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			1,233,853
Beginning balance	$ (979,147)	$ (877,536)	$ (930,624)	$ (835,505)
Net loss	$ (22,697)	(21,739)	$ (71,220)	(63,770)
Ending balance (in shares)	1,233,853		1,233,853
Ending balance	$ (1,001,844)	$ (899,275)	$ (1,001,844)	$ (899,275)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323	81,323	81,323
Ending balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,061,703)	(960,092)	(1,013,180)	(918,061)
Net loss	(22,697)	(21,739)	(71,220)	(63,770)
Ending balance	$ (1,084,400)	$ (981,831)	$ (1,084,400)	$ (981,831)